Analyst Ratings for ISIS Pharmaceuticals (ISIS)

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $49.71 (+22.1%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
8/12/2014 Laidlaw New Coverage Buy
(N/A)
52.00
(N/A)
34.79 40.73 17.07% Details
5/6/2014 Piper Jaffray
» Updated 5/23/2014
Upgrade Overweight
(Neutral)
42.00
(N/A)
25.60 40.73 59.1% Details
Like ISIS Ratings? Also take a look at SNY, SAN, GSK, BIIB

ISIS Ratings News